MA52743A - Sel de fumarate de 5-((5-méthyl-2-((3,4,5-triméthylphényl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one - Google Patents

Sel de fumarate de 5-((5-méthyl-2-((3,4,5-triméthylphényl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one

Info

Publication number
MA52743A
MA52743A MA052743A MA52743A MA52743A MA 52743 A MA52743 A MA 52743A MA 052743 A MA052743 A MA 052743A MA 52743 A MA52743 A MA 52743A MA 52743 A MA52743 A MA 52743A
Authority
MA
Morocco
Prior art keywords
amino
trimethylphenyl
oxazol
pyrimidin
benzo
Prior art date
Application number
MA052743A
Other languages
English (en)
Inventor
Håkan SCHULZ
Reed Warren Smith
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MA52743A publication Critical patent/MA52743A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA052743A 2018-05-24 2019-05-20 Sel de fumarate de 5-((5-méthyl-2-((3,4,5-triméthylphényl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one MA52743A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862675820P 2018-05-24 2018-05-24

Publications (1)

Publication Number Publication Date
MA52743A true MA52743A (fr) 2021-05-05

Family

ID=66770420

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052743A MA52743A (fr) 2018-05-24 2019-05-20 Sel de fumarate de 5-((5-méthyl-2-((3,4,5-triméthylphényl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one

Country Status (17)

Country Link
US (1) US20210198248A1 (fr)
EP (1) EP3802523A1 (fr)
JP (1) JP2021524458A (fr)
KR (1) KR20210012006A (fr)
CN (1) CN112154148A (fr)
AR (1) AR115426A1 (fr)
AU (1) AU2019272703B8 (fr)
BR (1) BR112020021620A2 (fr)
CA (1) CA3104745A1 (fr)
EA (1) EA202092759A1 (fr)
IL (1) IL278866A (fr)
MA (1) MA52743A (fr)
MX (1) MX2020011451A (fr)
SG (1) SG11202011396PA (fr)
TW (1) TW202016104A (fr)
WO (1) WO2019224141A1 (fr)
ZA (1) ZA202007930B (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2389372T1 (sl) * 2009-01-23 2016-02-29 Rigel Pharmaceuticals, Inc. Sestavki in postopki za inhibicijo poti JAK
ES2880622T3 (es) 2010-07-28 2021-11-25 Rigel Pharmaceuticals Inc Composiciones y procedimientos para la inhibición de la ruta de JAK
WO2013173506A2 (fr) * 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Procédé de traitement d'une dégradation musculaire
JP2016506930A (ja) * 2013-01-25 2016-03-07 ライジェル ファーマシューティカルズ, インコーポレイテッド 炎症性腸疾患を処置するための化合物および方法
WO2017007658A1 (fr) * 2015-07-07 2017-01-12 Rigel Pharmaceuticals, Inc. Combinaison à médiation immunitaire pour le traitement du cancer

Also Published As

Publication number Publication date
JP2021524458A (ja) 2021-09-13
AU2019272703A1 (en) 2021-01-14
US20210198248A1 (en) 2021-07-01
ZA202007930B (en) 2022-01-26
AR115426A1 (es) 2021-01-20
AU2019272703B2 (en) 2022-05-12
WO2019224141A1 (fr) 2019-11-28
SG11202011396PA (en) 2020-12-30
MX2020011451A (es) 2020-12-07
BR112020021620A2 (pt) 2021-01-26
CA3104745A1 (fr) 2019-11-28
TW202016104A (zh) 2020-05-01
EA202092759A1 (ru) 2021-04-09
KR20210012006A (ko) 2021-02-02
CN112154148A (zh) 2020-12-29
AU2019272703B8 (en) 2022-05-26
IL278866A (en) 2021-01-31
EP3802523A1 (fr) 2021-04-14

Similar Documents

Publication Publication Date Title
PE20180501A1 (es) Lactamas biciclicas y metodos de uso de las mismas
CA203353S (en) Temperature regulating garment
HUE058884T2 (hu) 8-[6-[3-(Amino)propoxi]-3-piridil]-1-izopropil-imidazo[4,5-c]kinolin-2-on származékok mint az ataxia telangiektázia mutáns (ATM) kináz szelektív modulátorai Huntington-betegség kezelésére
IL291384A (en) Process for preparing 5-(fluoro-4-imino-3-methyl)-1-tosyl-3,4 dihydropyrimidine -(1h)-one
MX2016009465A (es) Pirimidinas fusionadas como inhibidores del complejo p97.
PT3544457T (pt) Processo para pôr ou para tirar uma peça de vestuário na pessoa ou da pessoa que a veste ou para fechar, pôr, abrir ou tirar uma peça de bagagem transportada por uma pessoa
ZA202100571B (en) Isoxazoline compounds for controlling invertebrate pests
EP3640396C0 (fr) Cuir synthétique gratté
EP3870437C0 (fr) Cuir artificiel d'origine biologique
CA203352S (en) Temperature regulating garment
MA52743A (fr) Sel de fumarate de 5-((5-méthyl-2-((3,4,5-triméthylphényl)amino)pyrimidin-4-yl)amino)-benzo[d]oxazol-2(3h)-one
IL271253B1 (en) Negative setting for engraving finish that has a chip breaker mechanism
EP3794514C0 (fr) Synapse artificielle commutee
EP3668448C0 (fr) Implants de ménisque à base de collagène
GB201614849D0 (en) Angler's accessory
GB2579075B (en) Work machine with sensor enabled user control
IL265782B (en) Heterocyclic derivatives in compressed 2-(het)aryl-converted cyclics as pesticides
MA45685A (fr) Formes cristallines de 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide
ES1204761Y (es) Prenda con remate de cuello mejorado
UA36895S (uk) Півпальто жіноче хутрове «мозаїка». модель мв-372
GB2576764B (en) Textile Temperature Regulating Agents
TH182870B (th) เกลือทอซิเลทของ n-[3-[(4ar,7as)-2-อะมิโน-6-(5-ฟลูออโรพิริมิดิน-2-อิล)-4,4a,5,7-เททระไฮโดรพิร์โรโล[3,4-d][1,3]ไธอะซิน-7a-อิล]-4-ฟลูออโร-เฟนิล]-5-เมธอกซิ-ไพแรซีน-2-คาร์บอกแซมีด
UA98919U (ru) 4-этил-3-(феноксиметил)-5-((2-((5-феноксиметил)-4-фенил-4н-1,2,4-триазол-3-ил)тио)этил)тио)-4н-1,2,4-триазол, проявляющая диуретическую активность
PT3844337T (pt) Agentes reguladores de temperatura de têxteis
UA36930S (uk) Пальто жіноче хутрове «анжеліка». модель мв-392